Health
Sanofi’s mRNA COVID-19 vaccine candidate not ready this year, CEO says By Reuters – Investing.com
Sanofi’s mRNA COVID-19 vaccine candidate not ready this year, CEO says
PARIS (Reuters) – A COVID-19 vaccine candidate developed by Sanofi (NASDAQ:SNY) and U.S. group Translate Bio (NASDAQ:TBIO) “will not be ready this year,” the French drugmaker’s chief executive told Le Journal du Dimanche newspaper.
Clinical trials of this vaccine, which will be based on a technology known as mRNA — on which lean approved vaccines of Pfizer/BioNTech and Moderna (NASDAQ:MRNA) –, are expected to start this quarter.
In December last year, Sanofi had said it was targeting “earliest…
-
General17 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate
-
Noosa News24 hours agoDeath of German shepherd Arnie prompts Brisbane community action to protect pets caught up in crime
-
Noosa News17 hours agoPolice officer who tracked Toyah Cordingley’s phone gives evidence at Rajwinder Singh’s murder trial
-
General23 hours agoCrowe toasts talkback titan for platforming ‘voiceless’